Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ELOVL4 anticorps

L’anticorps Lapin Polyclonal anti-ELOVL4 a été validé pour WB. Il convient pour détecter ELOVL4 dans des échantillons de Humain.
N° du produit ABIN307133

Aperçu rapide pour ELOVL4 anticorps (ABIN307133)

Antigène

Voir toutes ELOVL4 Anticorps
ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))

Reactivité

  • 35
  • 15
  • 11
  • 5
  • 2
  • 2
Humain

Hôte

  • 36
Lapin

Clonalité

  • 36
Polyclonal

Conjugué

  • 18
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp ELOVL4 est non-conjugé

Application

  • 26
  • 23
  • 7
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  •  Réactivité croisée

    Humain

    Attributs du produit

    Elongation of very long chain fatty acids protein 4, ELOV4,Mutations in elongation of very long-chain fatty acid-4 (ELOVL4) are associated with autosomal dominant Stargardt-like macular degeneration (STGD3), with a five base-pair (5 bp) deletion mutation resulting in the loss of 51 carboxy-terminal amino acids and truncation of the protein. Elovl4 is expressed in the retina and only a limited number of mammalian other tissues, including skin, with unknown function. In a mouse model with the 5-bp deletion in the Elovl4 gene, mice in the heterozygous state (Elovl4(+/del)) demonstrate progressive photoreceptor degeneration. Homozygous mice (Elovl4(del/del)) display scaly, wrinkled skin, have severely compromised epidermal permeability barrier function, and die within a few hours after birth. Lipid analyses of epidermis from Elovl4(del/del) mice show a decrease in very long-chain fatty acids (VLFAs) in both the ceramide/glucosylceramide and the free fatty-acid fractions. ELOVL4 is required for generating VLFA critical for epidermal barrier function.

    Purification

    Ammonium Sulfate Precipitation

    Immunogène

    Synthetic peptdide derived from the human ELOV4 protein

    Isotype

    IgG
  • Indications d'application

    Antibody can be used for Western blotting (1-5 μg/mL starting dilution). Optimal concentration should be evaluated by serial dilutions.

    Restrictions

    For Research Use only
  • Buffer

    Provided as solution in phosphate buffered saline with 0.08 % sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
  • Antigène

    ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))

    Autre désignation

    ELOVL4

    UniProt

    Q9GZR5
Vous êtes ici:
Chat with us!